ADXS insider transaction filings

Ayala Pharmaceuticals, Inc. — 1 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-03-06. Screen ADXS transaction legs live →

Insider transaction summary — last 90 days

No Form 4 filings for ADXS between 2026-06-17 and 2026-09-15. The table below lists the most recent filings on record.

Recent Form 4 filings — Ayala Pharmaceuticals, Inc.

FiledFormInsiderReported transactionsSource
2024-03-064Israel Biotech Fund I, L.P. — Director, 10% owner
Israel Biotech Fund II, L.P. — Director, 10% owner
Israel Biotech Fund GP Partners, L.P. — Director, 10% owner
Israel Biotech Fund GP Partners II, L.P. — Director, 10% owner
I.B.F. Management Ltd. — Director, 10% owner
Option exercise (M): 3,750,000 (derivative) · Option exercise (M): 3,750,000 (derivative) · Option exercise (M): 1,500,000 (derivative) · Option exercise (M): 1,500,000 (derivative) · Option exercise (M): 2,250,000 (derivative) · Option exercise (M): 2,250,000 (derivative)EDGAR

Recent 8-K events — Ayala Pharmaceuticals, Inc.

FiledFormItems reportedSource
2024-04-198-K/A9.01 — Financial Statements and ExhibitsEDGAR
2024-04-038-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2024-03-298-K2.01 — Completion of Acquisition or Disposition of Assets
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-03-058-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ADXS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →